Among the commonly regulated FGF1 genes was Ets variant transcription factor 4 (ETV4), which has been shown to influence ER DNA binding activity in endometrial cancer cells [47], and glycolytic gene expression in breast cancer cells [48] (Fig. 8G). This evidence concerns the gene FGF1 and endometrial cancer.